Depression and cancer

Medical Journal of Australia

Volumn 1, Issue , 2012, Pages 13-17

  Couper, Jeremy W ^a   Pollard, Annabel C ^b   Clifton, Dianne A ^c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETOPOSIDE; PACLITAXEL; VINBLASTINE;

ARTICLE; DEPRESSION; EMOTION; GENERAL PRACTITIONER; HUMAN; MEDICAL PARAMETERS; MENTAL HEALTH; MENTAL HEALTH CARE; NEOPLASM; PSYCHOLOGIC ASSESSMENT; PSYCHOSOCIAL CARE; PSYCHOTHERAPY;

EID: 84908219008     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mjao12.10522     Document Type: Article

References (28)

1. Chochinov HM. Depression in cancer patients. Lancet Oncol 2001; 2: 499-505.
2. Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008; 110: 9-17.
3. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004; (32): 57-71.
4. Smith EM, Gomm SA, Dickens CM. Assessing the independent contribution to quality of life from anxiety and depression in advanced cancer. Palliat Med 2003; 17: 509-513.
5. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009; 115: 5349-5361.
6. Robson A, Scrutton F, Wilkinson L, MacLeod F. The risk of suicide in cancer patients: a review of the literature. Psychooncology 2010; 19: 1250-1258.
7. Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med 2012; 366: 1310-1318.
8. Clarke DM. No cancer health without mental health. Med J Aust 2010; 193 (5 Suppl): S43.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision. Washington, DC: American Psychiatric Publishing, 2000.
10. Holland JC, Bultz BD; National Comprehensive Cancer Network. The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw 2007; 5: 3-7.
11. Maguire P, Pitceathly C. Key communication skills and how to acquire them. BMJ 2002; 325: 697-700.
12. Butow P, Gilchrist J. How to build relationships with good communication. In: Hodgkinson K, Gilchrist J, editors. Psychosocial care of cancer patients: a health professional’s guide of what to say and do. Melbourne: Ausmed, 2008.
13. Brintzenhofe-Szoc KM, Levin TT, Li Y, et al. Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics 2009; 50: 383-391.
14. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12: 160-174.
15. Clarke DM, Kissane DW. Demoralization: its phenomenology and importance. Aust N Z J Psychiatry 2002; 36: 733-742.
16. Rackley S, Bostwick JM. Depression in medically ill patients. Psychiatr Clin North Am 2012; 35: 231-247.
17. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732-741.
18. Stiefel FC, Breitbart W., Holland JC. Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest 1989; 7: 479-491.
19. Ganz PA. Menopause and breast cancer: symptoms, late effects, and their management. Semin Oncol 2001; 28: 274-283.
20. Couper JW, Love AW, Dunai JV, et al. The psychological aftermath of prostate cancer treatment choices: a comparison of depression, anxiety and quality of life outcomes over the 12 months following diagnosis. Med J Aust 2009; 190 (7 Suppl): S86-S89.
21. Grassi L, Nanni MG, Uchitomi Y, Riba M. Pharmacotherapy of depression in people with cancer. In: Kissane DW, Maj M, Sartorius N, editors. Depression and cancer. Chichester, UK: John Wiley & Sons, 2010: 151-176.
22. Schwartz TL, Uderitz D. Tailoring antidepressant treatment: factors to individualize medication selection. Medscape Education 2011. http://www.medscape.org/viewarticle/755180 (accessed Dec 2011).
23. Rodin G, Lloyd N, Katz M, et al; Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care. The treatment of depression in cancer patients: a systematic review. Support Care Cancer 2007; 15: 123-136.
24. Rayner L, Price A, Hoptof M, Higginson IJ. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer 2011; 47: 702-712.
25. Morgan LC, Gartlehner G, Richard HA. Comparative effectiveness of second generation antidepressants in the pharmacologic treatment of adult depression. Eur Psychiatry 2012; 27: 1102.
26. Breitbart W. Do antidepressants reduce the effectiveness of tamoxifen? Psychooncology 2011; 20: 1-4.
27. Yap KY, Tay WL, Chui WK, Chan A. Clinically relevant drug interactions between anticancer drugs and psychotropic agents. Eur J Cancer Care (Engl) 2011; 20: 6-32.
28. Watson M, Kissane DW, editors. Handbook of psychotherapy in cancer care. Chichester, UK: John Wiley & Sons, 2011.